Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Pituitary ACTH Hypersecretion Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Ipsen SA
Alder Biopharmaceuticals Inc
Orphagen Pharmaceuticals, Inc
Isis Pharmaceuticals, Inc
Cyclacel Pharmaceuticals, Inc
Novartis AG
ElexoPharm GmbH
Corcept Therapeutics Incorporated
Cortendo AB
By Type:
CORT-125134
AT-814
BIM-23A758
Others
ATR-101
COR-005
ISIS-GCCRRx
By Application:
Hospital
Clinic
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Pituitary ACTH Hypersecretion Drug Market Overview 2018-2029
-
1.1 China Pituitary ACTH Hypersecretion Drug Industry Development Overview
-
1.2 China Pituitary ACTH Hypersecretion Drug Industry Development History
-
1.3 China Pituitary ACTH Hypersecretion Drug Industry Market Size (2018-2029)
-
1.4 China Pituitary ACTH Hypersecretion Drug Market Analysis by Type from Production Side
-
1.4.1 China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of CORT-125134 (2018-2029)
-
1.4.2 China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of AT-814 (2018-2029)
-
1.4.3 China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of BIM-23A758 (2018-2029)
-
1.4.4 China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.5 China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of ATR-101 (2018-2029)
-
1.4.6 China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of COR-005 (2018-2029)
-
1.4.7 China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of ISIS-GCCRRx (2018-2029)
-
1.5 China Pituitary ACTH Hypersecretion Drug Market Analysis by Application from Consumption End
-
1.5.1 China Pituitary ACTH Hypersecretion Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Pituitary ACTH Hypersecretion Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.3 China Pituitary ACTH Hypersecretion Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Pituitary ACTH Hypersecretion Drug Market Analysis by Region
-
1.6.1 North China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Pituitary ACTH Hypersecretion Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Pituitary ACTH Hypersecretion Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Pituitary ACTH Hypersecretion Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Pituitary ACTH Hypersecretion Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Pituitary ACTH Hypersecretion Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Pituitary ACTH Hypersecretion Drug Industry Development
Chapter 3 Pituitary ACTH Hypersecretion DrugIndustry Chain Analysis
-
3.1 Pituitary ACTH Hypersecretion Drug Industry Chain
-
3.2 Pituitary ACTH Hypersecretion Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Pituitary ACTH Hypersecretion Drug Market
-
3.3 Pituitary ACTH Hypersecretion Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Pituitary ACTH Hypersecretion Drug Market
Chapter 4 China Pituitary ACTH Hypersecretion Drug Market, by Type
-
4.1 China Pituitary ACTH Hypersecretion Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Pituitary ACTH Hypersecretion Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of CORT-125134
-
4.5.2 China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of AT-814
-
4.5.3 China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of BIM-23A758
-
4.5.4 China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of Others
-
4.5.5 China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of ATR-101
-
4.5.6 China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of COR-005
-
4.5.7 China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of ISIS-GCCRRx
Chapter 5 China Pituitary ACTH Hypersecretion Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Pituitary ACTH Hypersecretion Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate, by Application
-
5.5.1 China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate of Hospital
-
5.5.2 China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate of Clinic
-
5.5.3 China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate of Others
Chapter 6 China Pituitary ACTH Hypersecretion Drug Market, by Region
-
6.1 China Pituitary ACTH Hypersecretion Drug Production Volume and Production Value, by Region
-
6.2 China Pituitary ACTH Hypersecretion Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Pituitary ACTH Hypersecretion Drug Market Analysis
-
7.1 North China Pituitary ACTH Hypersecretion Drug Market, by Type
-
7.2 North China Pituitary ACTH Hypersecretion Drug Market, by Application
Chapter 8 Central China Pituitary ACTH Hypersecretion Drug Market Analysis
-
8.1 Central China Pituitary ACTH Hypersecretion Drug Market, by Type
-
8.2 Central China Pituitary ACTH Hypersecretion Drug Market, by Application
Chapter 9 South China Pituitary ACTH Hypersecretion Drug Market Analysis
-
9.1 South China Pituitary ACTH Hypersecretion Drug Market, by Type
-
9.2 South China Pituitary ACTH Hypersecretion Drug Market, by Application
Chapter 10 East China Pituitary ACTH Hypersecretion Drug Market Analysis
-
10.1 East China Pituitary ACTH Hypersecretion Drug Market, by Type
-
10.2 East China Pituitary ACTH Hypersecretion Drug Market, by Application
Chapter 11 Northeast China Pituitary ACTH Hypersecretion Drug Market Analysis
-
11.1 Northeast China Pituitary ACTH Hypersecretion Drug Market, by Type
-
11.2 Northeast China Pituitary ACTH Hypersecretion Drug Market, by Application
Chapter 12 Southwest China Pituitary ACTH Hypersecretion Drug Market Analysis
-
12.1 Southwest China Pituitary ACTH Hypersecretion Drug Market, by Type
-
12.2 Southwest China Pituitary ACTH Hypersecretion Drug Market, by Application
Chapter 13 Northwest China Pituitary ACTH Hypersecretion Drug Market Analysis
-
13.1 Northwest China Pituitary ACTH Hypersecretion Drug Market, by Type
-
13.2 Northwest China Pituitary ACTH Hypersecretion Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Ipsen SA
-
14.1.1 Ipsen SA Company Profile
-
14.1.2 Ipsen SA Pituitary ACTH Hypersecretion Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Alder Biopharmaceuticals Inc
-
14.2.1 Alder Biopharmaceuticals Inc Company Profile
-
14.2.2 Alder Biopharmaceuticals Inc Pituitary ACTH Hypersecretion Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Orphagen Pharmaceuticals, Inc
-
14.3.1 Orphagen Pharmaceuticals, Inc Company Profile
-
14.3.2 Orphagen Pharmaceuticals, Inc Pituitary ACTH Hypersecretion Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Isis Pharmaceuticals, Inc
-
14.4.1 Isis Pharmaceuticals, Inc Company Profile
-
14.4.2 Isis Pharmaceuticals, Inc Pituitary ACTH Hypersecretion Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Cyclacel Pharmaceuticals, Inc
-
14.5.1 Cyclacel Pharmaceuticals, Inc Company Profile
-
14.5.2 Cyclacel Pharmaceuticals, Inc Pituitary ACTH Hypersecretion Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Profile
-
14.6.2 Novartis AG Pituitary ACTH Hypersecretion Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 ElexoPharm GmbH
-
14.7.1 ElexoPharm GmbH Company Profile
-
14.7.2 ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Corcept Therapeutics Incorporated
-
14.8.1 Corcept Therapeutics Incorporated Company Profile
-
14.8.2 Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Cortendo AB
-
14.9.1 Cortendo AB Company Profile
-
14.9.2 Cortendo AB Pituitary ACTH Hypersecretion Drug Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Pituitary ACTH Hypersecretion Drug Industry Research Conclusions
-
15.2 Pituitary ACTH Hypersecretion Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Pituitary ACTH Hypersecretion Drug Industry Market Size (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of CORT-125134 (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of AT-814 (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of BIM-23A758 (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of ATR-101 (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of COR-005 (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume, Production Value and Growth Rate of ISIS-GCCRRx (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Pituitary ACTH Hypersecretion Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate from 2018-2029
-
Figure Pituitary ACTH Hypersecretion Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Pituitary ACTH Hypersecretion Drug Market Share by Type in 2018
-
Figure China Pituitary ACTH Hypersecretion Drug Market Share by Type in 2023
-
Figure China Pituitary ACTH Hypersecretion Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of CORT-125134 (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of AT-814 (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of BIM-23A758 (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of ATR-101 (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of COR-005 (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume and Growth Rate of ISIS-GCCRRx (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Market Share by Application in 2018
-
Figure China Pituitary ACTH Hypersecretion Drug Market Share by Application in 2023
-
Figure China Pituitary ACTH Hypersecretion Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Market Size and Growth Rate of Others (2018-2023)
-
Table China Pituitary ACTH Hypersecretion Drug Production Volume by Region (2018-2023)
-
Table China Pituitary ACTH Hypersecretion Drug Production Volume Share by Region (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Volume Share by Region (2018-2023)
-
Table China Pituitary ACTH Hypersecretion Drug Production Value by Region (2018-2023)
-
Table China Pituitary ACTH Hypersecretion Drug Production Value Share by Region (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Production Value Share by Region (2018-2023)
-
Table China Pituitary ACTH Hypersecretion Drug Sales Volume by Region (2018-2023)
-
Table China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Region (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Region (2018-2023)
-
Table China Pituitary ACTH Hypersecretion Drug Sales Value by Region (2018-2023)
-
Table China Pituitary ACTH Hypersecretion Drug Sales Value Share by Region (2018-2023)
-
Figure China Pituitary ACTH Hypersecretion Drug Sales Value Share by Region (2018-2023)
-
Table North China Pituitary ACTH Hypersecretion Drug Production Volume by Type (2018-2023)
-
Table North China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Figure North China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Table North China Pituitary ACTH Hypersecretion Drug Sales Volume by Application (2018-2023)
-
Table North China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Pituitary ACTH Hypersecretion Drug Production Volume by Type (2018-2023)
-
Table Central China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Table Central China Pituitary ACTH Hypersecretion Drug Sales Volume by Application (2018-2023)
-
Table Central China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Table South China Pituitary ACTH Hypersecretion Drug Production Volume by Type (2018-2023)
-
Table South China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Figure South China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Table South China Pituitary ACTH Hypersecretion Drug Sales Volume by Application (2018-2023)
-
Table South China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Table East China Pituitary ACTH Hypersecretion Drug Production Volume by Type (2018-2023)
-
Table East China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Figure East China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Table East China Pituitary ACTH Hypersecretion Drug Sales Volume by Application (2018-2023)
-
Table East China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Pituitary ACTH Hypersecretion Drug Production Volume by Type (2018-2023)
-
Table Northeast China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Pituitary ACTH Hypersecretion Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Pituitary ACTH Hypersecretion Drug Production Volume by Type (2018-2023)
-
Table Southwest China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Pituitary ACTH Hypersecretion Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Pituitary ACTH Hypersecretion Drug Production Volume by Type (2018-2023)
-
Table Northwest China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Pituitary ACTH Hypersecretion Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Pituitary ACTH Hypersecretion Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Pituitary ACTH Hypersecretion Drug Sales Volume Share by Application (2018-2023)
-
Table Ipsen SA Company Profile
-
Table Ipsen SA Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
Table Alder Biopharmaceuticals Inc Company Profile
-
Table Alder Biopharmaceuticals Inc Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
Table Orphagen Pharmaceuticals, Inc Company Profile
-
Table Orphagen Pharmaceuticals, Inc Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
Table Isis Pharmaceuticals, Inc Company Profile
-
Table Isis Pharmaceuticals, Inc Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
Table Cyclacel Pharmaceuticals, Inc Company Profile
-
Table Cyclacel Pharmaceuticals, Inc Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
Table ElexoPharm GmbH Company Profile
-
Table ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
Table Corcept Therapeutics Incorporated Company Profile
-
Table Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
Table Cortendo AB Company Profile
-
Table Cortendo AB Pituitary ACTH Hypersecretion Drug Revenue, Price and Gross (2018-2023)
-
